Clover Health is trading at $5.08, up +10.99% in pre-market after CMS awarded its 2027 PPO Medicare Advantage plans 5 Stars.

  • Coverage linked the October 8 announcement to an after-hours share rise; the ratings affect 2028 payments, and the PPO rating allows year-round enrollment.
  • Its HMO plan earned 4.5 Stars. The 5-Star calculation excludes 20 measures under a court decision being appealed; including them would produce a 4.5-Star rating.